Randolph Co Inc acquired a new position in Procter & Gamble Company (The) (NYSE:PG – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 4,931 shares of the company’s stock, valued at approximately $716,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in PG. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter worth $26,000. Montgomery Financial Services LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at $28,000. Paladin Partners LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at $29,000. Toews Corp ADV bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at $37,000. Finally, Evergreen Advisors LLC purchased a new stake in shares of Procter & Gamble in the 1st quarter worth $37,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
- Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
- Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
- Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
- Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook
Procter & Gamble Stock Performance
Shares of NYSE PG opened at $161.21 on Monday. The stock has a market cap of $373.64 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The firm has a fifty day moving average price of $148.41 and a 200-day moving average price of $147.12. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. The company had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. Procter & Gamble’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.99 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.51%.
Insider Buying and Selling at Procter & Gamble
In related news, CFO Andre Schulten sold 3,914 shares of the stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the completion of the sale, the chief financial officer owned 65,618 shares in the company, valued at approximately $9,536,920.12. This trade represents a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Gama sold 2,225 shares of the stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $323,381.50. Following the sale, the chief executive officer owned 51,124 shares of the company’s stock, valued at $7,430,362.16. This represents a 4.17% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 15,135 shares of company stock valued at $2,189,970. 0.23% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on PG shares. Royal Bank Of Canada set a $169.00 target price on Procter & Gamble in a report on Friday. Evercore raised Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a report on Tuesday, October 6th. Morgan Stanley upped their price target on Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a research report on Friday. UBS Group set a $166.00 price target on Procter & Gamble in a research report on Friday. Finally, Citigroup raised their price objective on Procter & Gamble from $180.00 to $187.00 and gave the stock a “buy” rating in a research note on Friday. Fifteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $168.90.
Read Our Latest Research Report on PG
Procter & Gamble Company Profile
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Read More
- Five stocks we like better than Procter & Gamble
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
